PXS--Pharmaxis Ltd

[stolwyk]

2 March: Expands senior management team.
http://stocknessmonster.com/news-ite...E=ASX&N=361578

Bought on 17 Sept 2004 for 84 cents; now $1.30

[stolwyk]

8 March: Updated Investor Presentation:

http://stocknessmonster.com/news-his...=ASX&Year=2005

[stolwyk]

March 31 quarterly report:

http://stocknessmonster.com/news-ite...E=ASX&N=366218

Cash $36.9 mill

[msgoldenhair]

PXS is having a good run atm...nice chart...apparently US investors are buying in on

[stolwyk]

Yes, I am very pleased with it.

There is a somewhat constant push, sometimes slow but then picking up speed.

See how we go.

Gerry

[stolwyk]

Hit $1.85, retraced, now $1.73

Graph still steep:

http://bigcharts.marketwatch.com/jav...XS&time=&freq=

STO was 100, now 83

[stolwyk]

US FDA GRANTS BRONCHITOL ORPHAN DRUG STATUS FOR
TREATMENT OF CYSTIC FIBROSIS


http://stocknessmonster.com/news-ite...E=ASX&N=375529

[stolwyk]

Commitments Test Entity - Fourth Quarter Report

Outflow: $3.05 mill

Cash: $33.4 mill





Share price: 1.86

[stolwyk]

Quarterly Report to Shareholders
http://stocknessmonster.com/news-ite...E=ASX&N=378288

[stolwyk]

Lists ADRs on NASDAQ

http://stocknessmonster.com/news-ite...E=ASX&N=378990

"Pharmaxis Ltd (ASX:PXS), announced today that it has received approval from NASDAQ to list its American Depositary Receipts (ADRs) on the NASDAQ National Market under the symbol PXSL (CUSIP number: 71715J
10 5).

No new shares will be issued in conjunction with the listing and one ADR will continue to be equivalent to 15 Pharmaxis ordinary shares. The Bank of New York remains the depositary bank".

Share price: $2.07